Pharmaceuticals, Biotechnology and Life Sciences
– Anticipate Emergency Use Submission for SARS-CoV-2Antibody Biosensor Test in the Second Half of 2021- – $14 Million in Cash,…
Hamilton, Bermuda, May 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that…
Together with SCYNEXIS’ $93M cash balance at 12/31/20, the non-dilutive capital injections from this term loan, the recent licensing payments…
TORRANCE, May 13, 2021 (GLOBE NEWSWIRE) — Premier Information Management, Inc. (OTC: PIFR) announced today that it has entered into…
– Established cGMP manufacturing and development agreement with Catalent for otoferlin dual-vector gene therapy, DB-OTO – – Successfully completed the second…
First Patient Dosed in Validive® Phase 2b/3 VOICE Clinical TrialCamsirubicin Run-in Clinical Trial Now Planned to Start in 2H 2021Potential…
AUSTIN, Texas, May 13, 2021 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…
– Completed $20M private placement financing with 3D Investment Partners – – Entered into partnership with BARDA to evaluate MN-166 for…
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed…
Received $1.0 Million Milestone Payment and Recognized $5.7 Million of License Revenue Under Exclusive License Agreement with 3D Medicines for…